Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Optical coherence tomography should be part of the routine monitoring of patients with multiple sclerosis: Commentary.
Demographic and clinical factors associated with changes in employment in multiple sclerosis.
Potential therapeutic benefit of c1-esterase inhibitor in neuromyelitis optica evaluated in vitro and in an experimental rat model.
Baló's concentric sclerosis: imaging findings and pathological correlation.
Role of TRIF Small Interference RNA (siRNA) in Chronic Experimental Allergic Encephalomyelitis (EAE).
Prevalence and risk factors of low bone mineral density in patients with multiple sclerosis.
Accurate GM atrophy quantification in MS using lesion-filling with co-registered 2D lesion masks.
Anti-aquaporin-4 antibody-positive dorsal midbrain syndrome.
Astrocyte response to IFN-γ limits IL-6-mediated microglia activation and progressive autoimmune encephalomyelitis.
Using perceptive computing in multiple sclerosis - the Short Maximum Speed Walk test.
Clinical experience with THC:CBD oromucosal spray in patients with multiple sclerosis-related spasticity.
Cardiovascular risk factors are associated with increased lesion burden and brain atrophy in multiple sclerosis.
IL-27-induced modulation of autoimmunity and its therapeutic potential.
[Characteristics of coping strategies in patients with multiple sclerosis(review)].
A rare case of Balo concentric sclerosis showing unusual clinical improvement and response with oral prednisolone.
Erratum to: Assessment of cardiac safety during fingolimod treatment initiation in a real-world relapsing multiple sclerosis population: a phase 3b, open-label study.
Identification of Bax-Interacting Proteins in Normal Oligodendrocyte Progenitors during Glutamate Excitotoxicity and Perinatal Hypoxia-Ischemia.
Restless legs syndrome associated with major diseases: A systematic review and new concept.
Study of type a and B behavior patterns in patients with multiple sclerosis in an Iranian population.
Multiple sclerosis: The elevated antibody response to Epstein-Barr virus primarily targets, but is not confined to, the glycine-alanine repeat of Epstein-Barr nuclear antigen-1.
Effects of long-term whole-body vibration training on mobility in patients with multiple sclerosis: A meta-analysis of randomized controlled trials.
Therapeutic effects of nonerythropoietic erythropoietin analog ARA290 in experimental autoimmune encephalomyelitis rat.
Kif13b Regulates PNS and CNS Myelination through the Dlg1 Scaffold.
Systematic Review and meta-analysis of the Efficacy of sphingosine-1-phosphate (S1P) receptor agonist FTY720 (fingolimod) in Animal Models of Stroke.
Novel Targets in Multiple Sclerosis: to Oxidative Stress and Beyond.
Pages
« first
‹ previous
…
453
454
455
456
457
458
459
460
461
…
next ›
last »